Advanced search
Publication Cover
OncoImmunology Volume 8, 2019 - Issue 2
Submit an article Journal homepage
2,270
Views
37
CrossRef citations to date
0
Altmetric
Original Research

Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy

Jing LiuCancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
,
Elisa A. RozemanDivision of Molecular Oncology & Immunology, Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
,
Jake S. O’DonnellCancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia;Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia;School of Medicine, University of Queensland, Herston, Queensland, Australia
,
Stacey AllenCancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
,
Lorenzo FanchiDivision of Molecular Oncology & Immunology, Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsORCID Iconhttp://orcid.org/0000-0002-5763-6726
ORCID Icon,
Mark J. SmythImmunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia;School of Medicine, University of Queensland, Herston, Queensland, Australia
,
Christian U. BlankDivision of Molecular Oncology & Immunology, Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
&
Michele W.L. TengCancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia;School of Medicine, University of Queensland, Herston, Queensland, AustraliaCorrespondence[email protected]
 show all
Article: e1546068 | Received 12 Jun 2018, Accepted 02 Nov 2018, Published online: 22 Nov 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.